NACL Industries (NACLIND)
CyclicalFairStock Score: 6/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹166.54 |
| Market Cap | ₹3,901.09 Cr |
| P/E Ratio | 333.08 |
| ROCE | -7.8% |
| ROE | -3.36% |
| Dividend Yield | 0% |
| Profit Growth | 64.83% |
| Debt/Equity | 0.46 |
| Sales Growth | -12.82% |
| Promoter Holding | 53.74% |
| 52-Week Range | ₹112.62 — ₹259.65 |
| Sector | Fertilizers & Agrochemicals |
| Book Value | ₹29.16 |
Strengths
- Sales grew 18.84%, showing underlying demand for its products.
- Latest quarter revenue of ₹318 Cr gives the company meaningful scale.
- Promoter holding of 53.74% aligns management's interests with minority shareholders.
- Piotroski F-Score of 6/9 suggests the financial statements are not showing acute distress.
Concerns
- Latest quarter net loss of ₹10 Cr means there are no earnings to justify a P/E multiple.
- Negative ROE of -3.36% and ROCE of -7.80% indicate capital is being destroyed.
- At P/B of 7.05, the market price is far above book value of ₹22.88, leaving no margin of safety.
- Debt/equity of 1.13 adds financial risk, and with no dividend, shareholders receive no income while waiting.
AI Analysis
At first glance, NACL Industries operates in pesticides and agrochemicals, a sector I can understand, but understanding doesn't equal attractive. The market price is ₹161.25, yet the latest quarter shows sales of ₹318 Cr and a net loss of ₹10 Cr. With P/E blank, the company is not earning its keep. Return on equity is -3.36%, and return on capital employed is -7.80%. Those are value-destroying numbers. A business must earn more than its cost of capital; this one is burning it. Sales growth of 18.84% sounds fine, but growth without profit is just a bigger engine losing money. The reported 'profit growth' of 71.96% looks like arithmetic on a negative base, not real earnings power. Book value is only ₹22.88, so at ₹161.25, I'm paying 7.05 times book for a company with negative returns. That gives no margin of safety. Debt/equity of 1.13 adds leverage to a weak returns profile, and with no dividend, shareholders get no cash while they wait. The 52-week range makes it clear the market has repriced the stock from ₹285.80 down to ₹161.25, but a falling price is not automatically value. Promoter holding of 53.74% is a plus; at least those running it have skin in the game. The Piotroski F-score of 6/9 also hints at no immediate financial distress, but that is a low bar. The FairStock score of 9/100 is consistent with my reading. I need evidence of durable profits, positive ROCE, and deleveraging before I would invest. The margin of safety is simply absent. This is a cyclical or turnaround situation, and the fundamentals have not yet turned. I'll wait on the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer